Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 11 studies | 35% ± 12% | |
lung | 11 studies | 40% ± 16% | |
intestine | 8 studies | 29% ± 14% | |
kidney | 5 studies | 26% ± 11% | |
brain | 5 studies | 34% ± 9% | |
placenta | 4 studies | 24% ± 5% | |
eye | 4 studies | 28% ± 10% | |
uterus | 4 studies | 38% ± 6% | |
pancreas | 3 studies | 51% ± 21% | |
bone marrow | 3 studies | 22% ± 8% | |
lymph node | 3 studies | 23% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 3490.13 | 245 / 245 | 99% | 18.25 | 499 / 502 |
thymus | 100% | 4352.52 | 653 / 653 | 99% | 21.55 | 601 / 605 |
kidney | 100% | 3569.44 | 89 / 89 | 99% | 15.76 | 892 / 901 |
adrenal gland | 100% | 5713.45 | 258 / 258 | 99% | 16.44 | 227 / 230 |
brain | 98% | 1620.57 | 2601 / 2642 | 99% | 11.52 | 699 / 705 |
breast | 100% | 4655.69 | 459 / 459 | 97% | 17.33 | 1083 / 1118 |
ovary | 100% | 3316.49 | 180 / 180 | 97% | 10.75 | 415 / 430 |
stomach | 100% | 3449.01 | 359 / 359 | 95% | 10.38 | 273 / 286 |
lung | 100% | 4142.62 | 578 / 578 | 95% | 12.01 | 1099 / 1155 |
pancreas | 100% | 2796.27 | 328 / 328 | 95% | 11.37 | 169 / 178 |
uterus | 100% | 3823.18 | 170 / 170 | 94% | 8.97 | 432 / 459 |
intestine | 100% | 3651.63 | 966 / 966 | 93% | 10.26 | 491 / 527 |
bladder | 100% | 3565.81 | 21 / 21 | 92% | 9.14 | 465 / 504 |
liver | 100% | 2558.41 | 226 / 226 | 92% | 10.96 | 373 / 406 |
esophagus | 100% | 2992.11 | 1445 / 1445 | 92% | 11.17 | 168 / 183 |
skin | 100% | 2791.41 | 1808 / 1809 | 89% | 10.34 | 422 / 472 |
adipose | 100% | 4555.12 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 4318.44 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 5.98 | 1 / 1 |
blood vessel | 100% | 3913.55 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 2414.26 | 854 / 861 | 0% | 0 | 0 / 0 |
muscle | 99% | 1840.02 | 791 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 97% | 9.60 | 28 / 29 |
peripheral blood | 95% | 3302.72 | 885 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 91% | 7.78 | 41 / 45 |
eye | 0% | 0 | 0 / 0 | 79% | 7.61 | 63 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006915 | Biological process | apoptotic process |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0050848 | Biological process | regulation of calcium-mediated signaling |
GO_0043524 | Biological process | negative regulation of neuron apoptotic process |
GO_0007626 | Biological process | locomotory behavior |
GO_0005795 | Cellular component | Golgi stack |
GO_0000139 | Cellular component | Golgi membrane |
GO_0016020 | Cellular component | membrane |
GO_0005515 | Molecular function | protein binding |
Gene name | TMBIM4 |
Protein name | TMBIM4 protein (Transmembrane BAX inhibitor motif containing 4) Transmembrane BAX inhibitor motif containing 4 Protein lifeguard 4 (Golgi anti-apoptotic protein) (Protein S1R) (Transmembrane BAX inhibitor motif-containing protein 4) (Z-protein) |
Synonyms | hCG_16706 CGI-119 LFG4 GAAP |
Description | FUNCTION: Anti-apoptotic protein which can inhibit apoptosis induced by intrinsic and extrinsic apoptotic stimuli. Can modulate both capacitative Ca2+ entry and inositol 1,4,5-trisphosphate (IP3)-mediated Ca2+ release. . |
Accessions | ENST00000286424.12 ENST00000545504.1 E7EWY5 F5H1S4 F5GXT9 Q9HC24 Q7Z782 ENST00000633367.1 G3V1R8 G3XAA5 ENST00000358230.8 ENST00000535812.1 ENST00000544599.5 ENST00000542724.5 ENST00000398033.8 ENST00000534930.1 G3V1M2 ENST00000545407.5 |